Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion type Assertion NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_head.
- NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion description "[The nuclear grade (U = 2321.0, P = 0.030), ER (U = 4343.5, P = 0.041) and CerbB-2 (U = 3894.0, P = 0.038) expression levels, and triple negative breast cancer diagnosing rate (?(2) = 4.719, P = 0.03) were disclosed more in BRCA1-associated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_provenance.
- NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion evidence source_evidence_literature NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_provenance.
- NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion SIO_000772 25337278 NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_provenance.
- NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion wasDerivedFrom befree-2016 NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_provenance.
- NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_assertion wasGeneratedBy ECO_0000203 NP1231628.RAQ34jiOIu84AgZLMPrPVQ0ncKnr614UNx_bwa9ysr28w130_provenance.